Cargando…

Altered miRNA expression in pulmonary sarcoidosis

BACKGROUND: miRNAs control important cellular functions including angiogenesis/angiostasis or fibrosis and reveal altered expression during pathological processes in the lung. METHODS: The aim of the study was to investigate the expression of selected miRNAs (miR-let7f, miR-15b, miR-16, miR-20a, miR...

Descripción completa

Detalles Bibliográficos
Autores principales: Kiszałkiewicz, Justyna, Piotrowski, Wojciech J., Pastuszak-Lewandoska, Dorota, Górski, Paweł, Antczak, Adam, Górski, Witold, Domańska-Senderowska, Daria, Migdalska-Sęk, Monika, Czarnecka, Karolina H., Nawrot, Ewa, Brzeziańska-Lasota, Ewa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4712597/
https://www.ncbi.nlm.nih.gov/pubmed/26768132
http://dx.doi.org/10.1186/s12881-016-0266-6
_version_ 1782410096111779840
author Kiszałkiewicz, Justyna
Piotrowski, Wojciech J.
Pastuszak-Lewandoska, Dorota
Górski, Paweł
Antczak, Adam
Górski, Witold
Domańska-Senderowska, Daria
Migdalska-Sęk, Monika
Czarnecka, Karolina H.
Nawrot, Ewa
Brzeziańska-Lasota, Ewa
author_facet Kiszałkiewicz, Justyna
Piotrowski, Wojciech J.
Pastuszak-Lewandoska, Dorota
Górski, Paweł
Antczak, Adam
Górski, Witold
Domańska-Senderowska, Daria
Migdalska-Sęk, Monika
Czarnecka, Karolina H.
Nawrot, Ewa
Brzeziańska-Lasota, Ewa
author_sort Kiszałkiewicz, Justyna
collection PubMed
description BACKGROUND: miRNAs control important cellular functions including angiogenesis/angiostasis or fibrosis and reveal altered expression during pathological processes in the lung. METHODS: The aim of the study was to investigate the expression of selected miRNAs (miR-let7f, miR-15b, miR-16, miR-20a, miR-27b, miR-128a, miR-130a, miR-192 miR-221, miR-222) in patients with pulmonary sarcoidosis (n = 94) and controls (n = 50). The expression was assessed by q-PCR in BALF cells and peripheral blood lymphocytes (PB lymphocytes). For statistical analysis, the Kruskal–Wallis test, Mann–Whitney U- test, Neuman–Keuls’ multiple comparison test, and Spearman’s rank correlation were used. RESULTS: In BALF cells, significantly higher expression of miR-192 and miR-221 and lower expression of miR-15b were found in patients than controls. MiR-27b, miR-192 and miR-221 expression was significantly higher in patients without parenchymal involvement (stages I) than those at stages II-IV. Patients with acute disease demonstrated significantly higher miR-27b, miR-192 and miR-221 expression than those with insidious onset. For PB lymphocytes, patients demonstrated significantly greater miR-15b, miR-27b, miR-192, miR-221 and miR-222 expression, but lower miR-let7f and miR-130a expression, than controls. Stage I patients demonstrated significantly higher miR-16 and miR-15b expression than those in stages II-IV, and patients with the acute form demonstrated higher miR-130a and miR-15b expression. In BALF cells, miR-16 and miR-20a expression was significantly higher in patients with lung volume restriction, and miR-let7f was higher in the PB lymphocytes in patients with obturation. Several correlations were observed between the pattern of miRNA expression, lung function parameters and selected laboratory markers. CONCLUSION: The obtained results suggest that the studied miRNAs play a role in the pathogenesis of sarcoidosis, and that some of them might have negative prognostic value. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12881-016-0266-6) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4712597
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-47125972016-01-15 Altered miRNA expression in pulmonary sarcoidosis Kiszałkiewicz, Justyna Piotrowski, Wojciech J. Pastuszak-Lewandoska, Dorota Górski, Paweł Antczak, Adam Górski, Witold Domańska-Senderowska, Daria Migdalska-Sęk, Monika Czarnecka, Karolina H. Nawrot, Ewa Brzeziańska-Lasota, Ewa BMC Med Genet Research Article BACKGROUND: miRNAs control important cellular functions including angiogenesis/angiostasis or fibrosis and reveal altered expression during pathological processes in the lung. METHODS: The aim of the study was to investigate the expression of selected miRNAs (miR-let7f, miR-15b, miR-16, miR-20a, miR-27b, miR-128a, miR-130a, miR-192 miR-221, miR-222) in patients with pulmonary sarcoidosis (n = 94) and controls (n = 50). The expression was assessed by q-PCR in BALF cells and peripheral blood lymphocytes (PB lymphocytes). For statistical analysis, the Kruskal–Wallis test, Mann–Whitney U- test, Neuman–Keuls’ multiple comparison test, and Spearman’s rank correlation were used. RESULTS: In BALF cells, significantly higher expression of miR-192 and miR-221 and lower expression of miR-15b were found in patients than controls. MiR-27b, miR-192 and miR-221 expression was significantly higher in patients without parenchymal involvement (stages I) than those at stages II-IV. Patients with acute disease demonstrated significantly higher miR-27b, miR-192 and miR-221 expression than those with insidious onset. For PB lymphocytes, patients demonstrated significantly greater miR-15b, miR-27b, miR-192, miR-221 and miR-222 expression, but lower miR-let7f and miR-130a expression, than controls. Stage I patients demonstrated significantly higher miR-16 and miR-15b expression than those in stages II-IV, and patients with the acute form demonstrated higher miR-130a and miR-15b expression. In BALF cells, miR-16 and miR-20a expression was significantly higher in patients with lung volume restriction, and miR-let7f was higher in the PB lymphocytes in patients with obturation. Several correlations were observed between the pattern of miRNA expression, lung function parameters and selected laboratory markers. CONCLUSION: The obtained results suggest that the studied miRNAs play a role in the pathogenesis of sarcoidosis, and that some of them might have negative prognostic value. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12881-016-0266-6) contains supplementary material, which is available to authorized users. BioMed Central 2016-01-14 /pmc/articles/PMC4712597/ /pubmed/26768132 http://dx.doi.org/10.1186/s12881-016-0266-6 Text en © Kiszałkiewicz et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Kiszałkiewicz, Justyna
Piotrowski, Wojciech J.
Pastuszak-Lewandoska, Dorota
Górski, Paweł
Antczak, Adam
Górski, Witold
Domańska-Senderowska, Daria
Migdalska-Sęk, Monika
Czarnecka, Karolina H.
Nawrot, Ewa
Brzeziańska-Lasota, Ewa
Altered miRNA expression in pulmonary sarcoidosis
title Altered miRNA expression in pulmonary sarcoidosis
title_full Altered miRNA expression in pulmonary sarcoidosis
title_fullStr Altered miRNA expression in pulmonary sarcoidosis
title_full_unstemmed Altered miRNA expression in pulmonary sarcoidosis
title_short Altered miRNA expression in pulmonary sarcoidosis
title_sort altered mirna expression in pulmonary sarcoidosis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4712597/
https://www.ncbi.nlm.nih.gov/pubmed/26768132
http://dx.doi.org/10.1186/s12881-016-0266-6
work_keys_str_mv AT kiszałkiewiczjustyna alteredmirnaexpressioninpulmonarysarcoidosis
AT piotrowskiwojciechj alteredmirnaexpressioninpulmonarysarcoidosis
AT pastuszaklewandoskadorota alteredmirnaexpressioninpulmonarysarcoidosis
AT gorskipaweł alteredmirnaexpressioninpulmonarysarcoidosis
AT antczakadam alteredmirnaexpressioninpulmonarysarcoidosis
AT gorskiwitold alteredmirnaexpressioninpulmonarysarcoidosis
AT domanskasenderowskadaria alteredmirnaexpressioninpulmonarysarcoidosis
AT migdalskasekmonika alteredmirnaexpressioninpulmonarysarcoidosis
AT czarneckakarolinah alteredmirnaexpressioninpulmonarysarcoidosis
AT nawrotewa alteredmirnaexpressioninpulmonarysarcoidosis
AT brzezianskalasotaewa alteredmirnaexpressioninpulmonarysarcoidosis